Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Schöffski (University Hospitals Leuven, Leuven, Belgium) talks to ecancertv at ASCO 2015 about the findings of a randomised phase III trial that point to eribulin as a promising new therapy for patients with advanced intermediate or high grade liposarcoma or leiomyosarcoma whose disease worsened after two or more lines of initial therapies.
Patrick Schöffski, MD, of University Hospitals Leuven discusses the phase 3 study comparing eribulin to dacarbazine in patients with liposarcomas or leiomyosarcomas, the 2 most common forms of sarcoma.
Dr. Robin Jones, a sarcoma expert from Seattle Cancer Care Alliance, gives us a clear picture of long-term disease control outcomes and various studies focused on progress in treating gastrointestinal stromal tumors.